Ensysce Biosciences (ENSCW) Return on Equity (2018 - 2025)

Ensysce Biosciences (ENSCW) has 8 years of Return on Equity data on file, last reported at 0.04% in Q4 2025.

• Return on Equity for Q4 2025 came in at 0.04%, down 2.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.04% (down 2.0% YoY), and the FY2024 annual result was 0.06%, down 11.0% from the prior year.
• Return on Equity grew to 0.04% in Q4 2025 per ENSCW's latest filing, from 0.05% in the prior quarter.
• Over five years, Return on Equity peaked at 0.11% in Q1 2023 and troughed at 1.97% in Q2 2022.
• A 5-year average of 0.13% and a median of 0.02% in 2025 frame the typical range for Return on Equity.
• The sharpest annual moves came in 2022 and 2023: Return on Equity sank 201 bps in 2022, then jumped 187 bps in 2023.
• A 5-year view of Return on Equity shows it stood at 0.05% in 2021, then dropped by 10 bps to 0.05% in 2022, then plunged by 1041 bps to 0.44% in 2023, then soared by 96 bps to 0.02% in 2024, then slumped by 127 bps to 0.04% in 2025.
• Business Quant data shows ENSCW's Return on Equity at 0.04% in Q4 2025, 0.05% in Q3 2025, and 0.02% in Q2 2025.